-
News | 2014.09.23
Signing of a technical agreement with Myanmar within the framework of the SEAe program
On September 17th, 2014 in Yangon, Myanmar, the Institut Pasteur, the Institut Pasteur in Cambodia, the National Health Laboratory, and the national Health authorities of the Republic of the Union of Myanmar signed a Technical Cooperation Agreement for the implementation of the project entitled “The threat of infectious encephalitis in Southeast Asia: Capacity building for a better...
-
News | 2014.09.29
Announcement of the signature for the Urugenomes Project
Monday, Sept. 15th, 2014 a press conference held in the Institut Pasteur in Montevideo for the announcement of a Human Genomics project’s signature, between the Institut Pasteur in Montevideo and National University of Seoul. This project, supported by the Korean fund of the Inter-American Development Bank aims to develop in Uruguay, capacities to sequence the human genome for applications...
-
News | 2014.10.01
Institut Pasteur in Cambodia: Awards for Vincent Deubel and Kruy Sun Lay
On September 26th, the Minister of Health in Cambodia, M. Mam Bun Heng has awarded the “Royal Order of Sahametrei Class Commander” to Prof. Vincent Deubel, Director of Institut Pasteur in Cambodia and the “Royal Order of Monisaraphon Class Commander” to Prof. Kruy Sun Lay, Deputy Director. The ceremony was graced with the presence of the French Ambassador in...
-
News | 2014.10.05
The Institut Pasteur International Network: a crucial partner against ebola
The Institut Pasteur International Network: a crucial partner against ebola
-
News | 2014.10.06
Cystic fibrosis: how a bacterium manipulates its host to eradicate an opponent
The main cause of death in patients suffering from cystic fibrosis is respiratory infection caused by different bacterial populations, which vary according to the age of the patient. Scientists at the Institut Pasteur and Inserm have identified a novel mechanism used by the Pseudomonas aeruginosa bacterium to hijack the immune system of its host in order to eradicate another bacterium,...
-
News | 2014.10.13
Randomized controlled trials for Ebola: practical and ethical issues
This article, published in The Lancet Journal on 10th, October 2014 deals with the ethics and practice of randomized controlled trials in the case of Ebola hemorrhagic fever epidemic. In the randomized trials patients are divided into different groups receiving various treatments, the distribution between the groups being formed by drawing of lots (also called randomization) compared to a...
-
News | 2014.10.16
Ebola & mobile technology: battling epidemics with big data
Thursday, October. 16th, 2014 the Institut Pasteur in Paris welcomed the “Académie Diplomatique Internationale” for a briefings on new analytical methods solving critical gaps in global public health. Flowminder made a presentation on methods consisting to use anonymized mobile phone network data with the aim to improve operational decision making in a range of areas including...
-
News | 2014.10.13
Human papillomavirus linked to auto-immune disease
Erosive oral lichen planus (OLP) is an auto-immune disease affecting skin and mucous membranes which results in an abnormal immune response against mucocutaneous cells. Today, scientists have proven that the immune cells involved in OLP are the same as those activated during an immune response to human papillomavirus (type HPV-16). This suggests a link between OLP and HPV.
-
News | 2014.10.22
Blood Ebola survivors tested as short-term treatment option
An international research consortium will assess whether treatment with antibodies in the blood of Ebola survivors could help infected patients to fight off the disease. If proven effective, this straightforward intervention could be scaled up in the short term and provide an urgently needed treatment option for patients in West Africa.
-
News | 2014.10.27
A bioinformatics tool to monitor the resistance and virulence of Klebsiella pneumoniae bacteria
By sequencing the genomes of several strains of Klebsiella pneumoniae, scientists have revealed their genetic profile and pinpointed the genes responsible for their multiple antibiotic resistance and virulence. They have used these results to compile a database for the scientific community, providing high-resolution genetic fingerprints and information on genes of medical importance. This should...
